Blueprint Medicines Corp
Total Trades
115
Buys
3
Sells
82
Largest Trade
N/A
Insiders
15
Institutional Funds
2
Inst. Value
$50K–$100K
Activist Filings
20
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Rossi Christina | CHIEF OPERATING OF… | SELL | $100K–$500K | 1K | $128.25 | Jul 8, 2025 |
| Carter Percy H. | CHIEF SCIENTIFIC O… | SELL | $100K–$500K | 1K | $128.25 | Jul 8, 2025 |
| Carter Percy H. | CHIEF SCIENTIFIC O… | SELL | $100K–$500K | 3K | $127.88 | Jun 5, 2025 |
| Albers Jeffrey W. | Director | EXERCISE | $100K–$500K | 5K | $36.05 | May 29, 2025 |
| Albers Jeffrey W. | Director | SELL | $500K+ | 5K | $101.14 | May 29, 2025 |
| Rossi Christina | CHIEF OPERATING OF… | SELL | $100K–$500K | 2K | $100.51 | May 21, 2025 |
| Rossi Christina | CHIEF OPERATING OF… | SELL | $100K–$500K | 2K | $101.75 | May 7, 2025 |
| Hurley Ariel | PRINCIPAL ACCOUNTI… | EXERCISE | $100K–$500K | 3K | $54.13 | May 7, 2025 |
| Hurley Ariel | PRINCIPAL ACCOUNTI… | SELL | $100K–$500K | 3K | $103.13 | May 7, 2025 |
| Haviland Kate | CHIEF EXECUTIVE OF… | SELL | $100K–$500K | 2K | $86.65 | Apr 3, 2025 |
| Rossi Christina | CHIEF OPERATING OF… | SELL | $100K–$500K | 2K | $95.02 | Mar 26, 2025 |
| Albers Jeffrey W. | Director | SELL | $500K+ | 6K | $88.80 | Mar 17, 2025 |
| Albers Jeffrey W. | Director | SELL | $500K+ | 8K | $87.80 | Mar 14, 2025 |
| Albers Jeffrey W. | Director | EXERCISE | $100K–$500K | 8K | $36.05 | Mar 14, 2025 |
| Rossi Christina | CHIEF OPERATING OF… | SELL | $100K–$500K | 2K | $95.14 | Feb 24, 2025 |
| Haviland Kate | CHIEF EXECUTIVE OF… | SELL | $100K–$500K | 1K | $110.24 | Jan 24, 2025 |
| Rossi Christina | CHIEF OPERATING OF… | SELL | $100K–$500K | 2K | $110.14 | Jan 24, 2025 |
| Albers Jeffrey W. | Director | SELL | $1M+ | 15K | $109.53 | Jan 24, 2025 |
| Albers Jeffrey W. | Director | EXERCISE | $100K–$500K | 10K | $36.05 | Jan 24, 2025 |
| Albers Jeffrey W. | Director | EXERCISE | $100K–$500K | 5K | $36.05 | Jan 15, 2025 |
| Albers Jeffrey W. | Director | SELL | $500K+ | 5K | $102.28 | Jan 15, 2025 |
| Hurley Ariel | PRINCIPAL ACCOUNTI… | SELL | $100K–$500K | 2K | $100.00 | Jan 15, 2025 |
| Hurley Ariel | PRINCIPAL ACCOUNTI… | EXERCISE | $50K–$100K | 2K | $36.05 | Jan 15, 2025 |
| Haviland Kate | CHIEF EXECUTIVE OF… | SELL | $100K–$500K | 2K | $96.60 | Dec 3, 2024 |
| Rossi Christina | CHIEF OPERATING OF… | SELL | $100K–$500K | 2K | $95.10 | Dec 2, 2024 |
| COATS LONNEL | Director | SELL | $1M+ | 20K | $94.31 | Nov 22, 2024 |
| COATS LONNEL | Director | EXERCISE | $500K+ | 9K | $70.75 | Nov 22, 2024 |
| Albers Jeffrey W. | Director | SELL | $500K+ | 5K | $102.00 | Nov 12, 2024 |
| Albers Jeffrey W. | Director | EXERCISE | $100K–$500K | 5K | $36.05 | Nov 12, 2024 |
| Namouni Fouad | PRESIDENT, R & D | SELL | $100K–$500K | 4K | $89.32 | Oct 4, 2024 |
| Landsittel Michael | CHIEF FINANCIAL OF… | SELL | $100K–$500K | 4K | $95.23 | Aug 19, 2024 |
| Durso-Bumpus Debra | CHIEF PEOPLE OFFICER | EXERCISE | $15K–$50K | 333 | $54.13 | Jul 2, 2024 |
| Durso-Bumpus Debra | CHIEF PEOPLE OFFICER | SELL | $15K–$50K | 333 | $111.15 | Jul 2, 2024 |
| Durso-Bumpus Debra | CHIEF PEOPLE OFFICER | SELL | $1M+ | 74K | $104.19 | Jun 25, 2024 |
| Durso-Bumpus Debra | CHIEF PEOPLE OFFICER | EXERCISE | $1M+ | 60K | $34.48 | Jun 25, 2024 |
| Carter Percy H. | CHIEF SCIENTIFIC O… | SELL | $100K–$500K | 4K | $105.13 | Jun 7, 2024 |
| Hewes L. Becker | CHIEF MEDICAL OFFI… | SELL | $100K–$500K | 2K | $104.91 | Jun 6, 2024 |
| Carter Percy H. | CHIEF SCIENTIFIC O… | SELL | $100K–$500K | 2K | $106.43 | Jun 5, 2024 |
| Hewes L. Becker | CHIEF MEDICAL OFFI… | SELL | $1M+ | 39K | $105.98 | Jun 4, 2024 |
| Hewes L. Becker | CHIEF MEDICAL OFFI… | EXERCISE | $1M+ | 25K | $59.21 | Jun 4, 2024 |
| Landsittel Michael | CHIEF FINANCIAL OF… | SELL | $100K–$500K | 5K | $95.00 | Apr 1, 2024 |
| Landsittel Michael | CHIEF FINANCIAL OF… | EXERCISE | $100K–$500K | 5K | $36.05 | Apr 1, 2024 |
| Albers Jeffrey W. | Director | SELL | $1M+ | 11K | $90.69 | Mar 27, 2024 |
| Albers Jeffrey W. | Director | SELL | $1M+ | 25K | $87.28 | Mar 22, 2024 |
| Albers Jeffrey W. | Director | EXERCISE | $100K–$500K | 25K | $7.11 | Mar 22, 2024 |
| Murray Christopher K. | CHIEF TECHNICAL OP… | EXERCISE | $100K–$500K | 5K | $54.13 | Mar 1, 2024 |
| Murray Christopher K. | CHIEF TECHNICAL OP… | SELL | $500K+ | 5K | $100.00 | Mar 1, 2024 |
| Albers Jeffrey W. | Director | SELL | $1M+ | 25K | $81.91 | Jan 29, 2024 |
| Albers Jeffrey W. | Director | EXERCISE | $100K–$500K | 25K | $7.13 | Jan 29, 2024 |
| Hurley Ariel | PRINCIPAL ACCOUNTI… | EXERCISE | $1K–$15K | 714 | $8.80 | Dec 26, 2023 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 2 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| DekaBank Deutsche Girozentrale | 733 | $50K–$100K | SH |
| HUNTINGTON NATIONAL BANK | 1 | <$1K | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
Pentwater Capital Management LP
SC 13G · Aug 14, 2025
6.0%
3.9M shares
T. Rowe Price Associates, Inc.
SC 13G/A · Aug 14, 2025
2.3%
1.5M shares
SC 13G/A · Aug 14, 2025
0.6%
375K shares
SC 13G · Jul 21, 2025
0.0%
0 shares
SC 13G · May 15, 2025
6.0%
3.9M shares
Wellington Management Group LLP
SC 13G/A · May 12, 2025
4.8%
3.1M shares
SC 13G/A · Apr 24, 2025
8.0%
5.1M shares
SC 13G/A · Feb 12, 2025
3.5%
2.2M shares
T. ROWE PRICE ASSOCIATES, INC. 52-0556948
SC 13G/A · Nov 14, 2024
8.5%
5.4M shares
T. ROWE PRICE ASSOCIATES, INC. 52-0556948
SC 13G/A · Apr 10, 2024
10.2%
6.3M shares
T. ROWE PRICE ASSOCIATES, INC. 52-0556948
SC 13G/A · Feb 14, 2024
8.9%
5.4M shares
SC 13G/A · Jan 24, 2024
10.8%
6.6M shares
The Vanguard Group - 23-1945930
SC 13G/A · Jan 10, 2024
10.1%
6.1M shares
SC 13G/A · Nov 13, 2023
7.7%
4.7M shares
T. ROWE PRICE ASSOCIATES, INC. 52-0556948
SC 13G/A · Feb 14, 2023
7.2%
4.3M shares
SC 13G/A · Jan 26, 2023
10.5%
6.3M shares
SC 13G/A · Jan 20, 2023
10.5%
6.3M shares
SC 13G/A · Nov 9, 2022
10.0%
6.0M shares
SC 13G · May 10, 2022
10.1%
6.0M shares
T. ROWE PRICE ASSOCIATES, INC. 52-0556948
SC 13G/A · Feb 14, 2022
7.7%
4.6M shares